Skip to main content

Animations

MJFF Publications

4501 - 4510 of 9117 Results
Title
Year
  • Year
  • 2018
  • 2020
  • 2018
  • 2017
  • 2018
  • 2015
  • 2025
  • 2020
  • 2016
  • 2013
  • Summary Details
    OPEN
    Title: Comparative sensitivity of the MoCA and Mattis Dementia Rating Scale‐2 in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27575
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Protein synthesis is suppressed in sporadic and familial Parkinson’s disease by LRRK2
    Journal Name: The FASEB Journal
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1096/fj.202001046r
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Evolving Applications, Technological Challenges and Future Opportunities in Neuromodulation: Proceedings of the Fifth Annual Deep Brain Stimulation Think Tank
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2017.00734
    Citation Count: 77
  • Summary Details
    OPEN
    Title: Predicting primary progressive aphasias with support vector machine approaches in structural MRI data
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2017.02.003
    Citation Count: 53
  • Summary Details
    OPEN
    Title: Small intestinal bacterial overgrowth in Parkinson's disease: Tribulations of a trial
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.04.003
    Citation Count: 36
  • Summary Details
    OPEN
    Title: Chemogenomic Profiling of Endogenous PARK2 Expression Using a Genome-Edited Coincidence Reporter
    Journal Name: ACS Chemical Biology
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/cb5010417
    Citation Count: 56
  • Summary Details
    OPEN
    Title: Healthcare access and utilization of deep brain stimulation and supplementary care in black and white patients with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2025.108057
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789
    Citation Count: 34
  • Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults
    2016
    Summary Details
    RESTRICTED
    Title: Substantia nigra hyperechogenicity is related to decline in verbal memory in healthy elderly adults
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.12974
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Diabetes is associated with postural instability and gait difficulty in Parkinson disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2013.01.016
    Citation Count: 124
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.